Skip to main content
logo
Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.45
-0.16 (-1.27%)
At close: Apr 17, 2026, 4:00 PM EDT
12.47
+0.02 (0.16%)
After-hours: Apr 17, 2026, 6:04 PM EDT

Generate Biomedicines Market Cap

Generate Biomedicines has a market cap or net worth of $1.59 billion as of April 17, 2026.

Market Cap
1.59B
Enterprise Value
1.43B
1-Year Change
n/a
Ranking
#2246
Category
Small-Cap
Stock Price
$12.45

Market Cap Chart

Since the IPO on February 27, 2026, Generate Biomedicines's market cap has decreased from $2.04B to $1.59B, a decrease of -22.19%.

History

DateMarket Cap% Change
Apr 17, 20261.59B-1.27%
Apr 16, 20261.61B0.88%
Apr 15, 20261.59B-3.03%
Apr 14, 20261.64B0.70%
Apr 13, 20261.63B12.18%
Apr 10, 20261.45B-1.04%
Apr 9, 20261.47B-3.43%
Apr 8, 20261.52B0.93%
Apr 7, 20261.51B-2.23%
Apr 6, 20261.54B-12.00%
Apr 2, 20261.75B3.31%
Apr 1, 20261.70B6.48%
Mar 31, 20261.59B8.60%
Mar 30, 20261.47B0.61%
Mar 27, 20261.46B-10.97%
Mar 26, 20261.64B8.62%
Mar 25, 20261.51B-1.66%
Mar 24, 20261.53B-3.91%
Mar 23, 20261.60B2.04%
Mar 20, 20261.56B-0.16%
Mar 19, 20261.57B4.06%
Mar 18, 20261.51B-4.45%
Mar 17, 20261.58B3.34%
Mar 16, 20261.52B-8.56%
Mar 13, 20261.67B-1.51%
Mar 12, 20261.69B4.40%
Mar 11, 20261.62B4.18%
Mar 10, 20261.56B0.33%
Mar 9, 20261.55B8.56%
Mar 6, 20261.43B-9.96%
Mar 5, 20261.59B7.51%
Mar 4, 20261.48B-2.93%
Mar 3, 20261.52B-1.97%
Mar 2, 20261.55B-23.94%
Feb 27, 20262.04B-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Biohaven1.65B
Nanobiotix1.64B
Oculis Holding AG1.62B
MBX Biosciences1.60B
Damora Therapeutics1.60B
Immunocore Holdings1.59B
Iovance Biotherapeutics1.59B
Monte Rosa Therapeutics1.58B
Market Cap Rankings